Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-21-027402
Filing Date
2021-04-19
Accepted
2021-04-19 19:27:16
Documents
2
Period of Report
2021-04-15

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 7917
2 POA DOCUMENT poa.txt EX-24.4_979911 2382
  Complete submission text file 0001209191-21-027402.txt   11749
Mailing Address 3005 FIRST AVENUE SEATTLE WA 98121
Business Address
HERSHBERG ROBERT (Reporting) CIK: 0001274139 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-40323 | Film No.: 21835891

Mailing Address 41S RIO GRANDE STREET SALT LAKE CITY UT 84101
Business Address 41S RIO GRANDE STREET SALT LAKE CITY UT 84101 (385) 269-0203
RECURSION PHARMACEUTICALS, INC. (Issuer) CIK: 0001601830 (see all company filings)

EIN.: 464099738 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)